Boehringer Ingelheim India recognized as Top Employer 2024
Boehringer Ingelheim India recognized as Top Employer 2024
Search
India
In India, Boehringer Ingelheim is one the fastest growing multinational pharmaceutical companies. Find out more about our presence in India here.
Chronic Kidney Disease
Chronic kidney disease affects approximately 850 million people worldwide which is more than ten percent of the population.
COVID-19: EFPIA Industry Information
The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
COVID-19 Q&A for Patients
Corona and COVID-19 can lead to many questions. We want to answer a few of them, provide some general information and give some recommendations.
COVID-19 Volunteering in Canada
Colleagues across Canada are doing their part during the pandemic by supporting their community’s needs. Click here to find out and learn more information.
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
NexGard Spectra launched in China
Early August 2018, NexGard Spectra (afoxolaner and milbemycin oxime), the first oral endectocide for dogs, was launched in China. Click here to learn more.
COVID-19 USA U.S. employees show gratitude #foreachother
Employees across the U.S. display Boehringer Ingelheim’s culture of caring during this challenging time. Click here to find out and learn more.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
Cat care interview veterinarian Dr Susan Little
We interviewed world-renowned feline healthcare specialist Dr Susan Little to get her thoughts on cat care. Click here to read and find out more.
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach is a herculean task – but also an innovation that carries huge potential. Learn more here.
World Patient Safety Day 2021
As a sign of support for World Patient Safety Day, Boehringer Ingelheim lights up buildings in orange. Click here to learn and find out more.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
World Heart Day 2021
The heart is one of the things with the potential to unite all of us as people. Click here to read patient stories about their heartbeat moment.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.
Protecting Animals and Humans
At Boehringer Ingelheim we are committed to ensuring the continued availability of our products for patients, customers and animals during the pandemic.
COVID-19 India - supporting community during the pandemic
Boehringer Ingelheim India was amongst the first few companies supporting local authorities in Maharashtra in this crisis. Click here to learn more.
Expectations towards our business partners
Boehringer Ingelheim utilises an extensive network of international suppliers. Click here to learn more about our expectations towards our suppliers.
Stroke Risk Factors Symptoms
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Find out more about risk factors and symptoms.
Travelling with dogs
What are some of the things we should consider when traveling with dogs? Click here to read our tips for a relaxing trip with your furry companion.
Podcast: Journeys through pulmonary fibrosis
As we speak to the courageous pulmonary fibrosis community, we hear heart-warming stories of determination, resilience and spirit. Click here to listen.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.
Collaborating with RDA in the UK
The Riding for the Disabled Association (RDA) provides therapy, achievement and enjoyment to people with disabilities all over the UK. Learn more here.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.